1. Home
  2. NEXR vs ISPC Comparison

NEXR vs ISPC Comparison

Compare NEXR & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NEXR

Nexera Technologies Ltd Ordinary Shares

N/A

Current Price

$3.05

Market Cap

4.2M

ML Signal

N/A

Logo iSpecimen Inc.

ISPC

iSpecimen Inc.

HOLD

Current Price

$2.01

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXR
ISPC
Founded
N/A
2009
Country
Israel
United States
Employees
38
N/A
Industry
Other Specialty Stores
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
3.8M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
NEXR
ISPC
Price
$3.05
$2.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.4M
44.5K
Earning Date
N/A
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.03
EPS
N/A
N/A
Revenue
N/A
$1,928,998.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.10
52 Week High
$4.22
$6.77

Technical Indicators

Market Signals
Indicator
NEXR
ISPC
Relative Strength Index (RSI) 78.06 39.02
Support Level $0.23 $0.20
Resistance Level N/A $4.49
Average True Range (ATR) 0.30 0.15
MACD 0.29 -0.01
Stochastic Oscillator 55.26 35.00

Price Performance

Historical Comparison
NEXR
ISPC

About NEXR Nexera Technologies Ltd Ordinary Shares

Nexera Technologies Ltd focuses on homeland security technologies, artificial intelligence-driven solutions, and detection systems through its subsidiaries and strategic collaborations. The company collaborates with technology partners to distribute and promote new systems such as 3D imaging and electromagnetic threat detection tools, autonomous security technologies, and multi-layered security ecosystems for critical infrastructure and high-traffic venues.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.

Share on Social Networks: